ASCFX Performance — Virtus Small-Cap Fund, Class R6
Data updated: 2026-09-11
ASCFX returned +23.45% year to date and +37.54% over one year to Jun 2026. Annualised returns are +18.95% over 3 years and +9.18% over 5 years. The fund beat its US Small Blend category average: $100 invested three years ago grew to $168, against $156 for the category, and to $138 over one year, against $133. Volatility over the past three years was 16.33% a year. In the 12 months to Jun 2026 the fund took in a net $10.1M, and assets reached $134.38M.
ASCFX Growth of $100
What $100 invested in Virtus Small-Cap Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Small Blend category average over the same months.
| Period | ASCFX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $138 | $133 |
| 3 years (Jul 2023 – Jun 2026) | $168 | $156 |
| 5 years (Jul 2021 – Jun 2026) | $155 | $141 |
| Since data start (Jul 2019 – Jun 2026) | $221 | $209 |
ASCFX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +23.45% |
| 1 year | +37.54% |
| 3 years (annualised) | +18.95% |
| 5 years (annualised) | +9.18% |
ASCFX Annual Returns
Calendar-year total returns of Virtus Small-Cap Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +23.45% |
| 2025 | +8.56% |
| 2024 | +19.60% |
| 2023 | +14.16% |
| 2022 | −18.08% |
| 2021 | +19.34% |
| 2020 | +17.08% |
| 2019 (Jul–Dec) | +5.43% |
ASCFX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.4% | +2.5% | −4.2% | +10.7% | +2.8% | +5.8% | — | — | — | — | — | — |
| 2025 | +2.9% | −5.5% | −6.3% | −1.4% | +5.7% | +2.7% | +1.4% | +8.4% | +2.9% | −2.5% | +1.3% | −0.2% |
| 2024 | −0.5% | +3.6% | +3.8% | −5.2% | +4.6% | −0.8% | +8.5% | +1.4% | +1.7% | −2.1% | +9.7% | −5.5% |
| 2023 | +6.5% | +0.9% | −2.3% | −2.2% | −0.8% | +6.9% | +3.1% | −3.4% | −3.5% | −5.1% | +5.5% | +9.1% |
| 2022 | −9.0% | +0.7% | −0.1% | −9.0% | +1.1% | −8.3% | +7.8% | −2.6% | −9.1% | +12.0% | +4.9% | −5.3% |
| 2021 | +2.8% | +6.7% | +0.8% | +3.1% | +0.2% | +1.0% | −1.1% | +2.9% | −3.4% | +5.7% | −4.1% | +3.9% |
| 2020 | −1.2% | −8.2% | −21.1% | +10.6% | +7.5% | +0.7% | +6.2% | +5.3% | −1.3% | +0.7% | +13.8% | +7.8% |
| 2019 | — | — | — | — | — | — | +1.5% | −3.1% | −0.4% | +2.0% | +3.9% | +1.6% |
ASCFX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 16.33%
- 3-year Sharpe ratio: 0.88 (vs 4.5% risk-free rate)
- Best month: +10.73% (Apr 2026)
- Worst month: −6.35% (Mar 2025)
ASCFX Fund Flows
Monthly money in and out of Virtus Small-Cap Fund, from SEC Form N-PORT.
- 12-month net flow: $10.1M
- 12-month gross sales (incl. reinvestments): $28.3M
- Sales ÷ redemptions: 1.55×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $4.3M | $2.2M | $2.1M |
| May 2026 | $2.2M | $1.3M | $913K |
| Apr 2026 | $4.5M | $1.7M | $2.8M |
| Mar 2026 | $872K | $1.1M | −$213K |
| Feb 2026 | $1.9M | $2.8M | −$951K |
| Jan 2026 | $5.1M | $1.4M | $3.7M |
| Dec 2025 | $5.4M | $1.5M | $3.9M |
| Nov 2025 | $930K | $1.2M | −$310K |
| Oct 2025 | $800K | $1.8M | −$974K |
| Sep 2025 | $321K | $637K | −$315K |
| Aug 2025 | $659K | $1.4M | −$717K |
| Jul 2025 | $1.3M | $1.2M | $134K |
ASCFX Assets Under Management
Net assets of Virtus Small-Cap Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $134.38M |
| 2026-03-31 | $106.29M |
| 2025-12-31 | $101.38M |
| 2025-09-30 | $105.09M |
| 2025-06-30 | $93.81M |
| 2025-03-31 | $88.49M |
| 2024-12-31 | $99.84M |
| 2024-09-30 | $100.30M |
| 2024-06-28 | $90.71M |
| 2024-03-28 | $94.92M |
| 2023-12-29 | $93.47M |
| 2023-09-29 | $92.16M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.